Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001974696 | SCV002214124 | uncertain significance | not provided | 2022-07-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). ClinVar contains an entry for this variant (Variation ID: 1436128). This variant has not been reported in the literature in individuals affected with CENPF-related conditions. This variant is present in population databases (rs140953760, gnomAD 0.2%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 632 of the CENPF protein (p.Gln632Arg). |
Ambry Genetics | RCV004042945 | SCV004924202 | uncertain significance | Inborn genetic diseases | 2021-08-02 | criteria provided, single submitter | clinical testing | The c.1895A>G (p.Q632R) alteration is located in exon 12 (coding exon 11) of the CENPF gene. This alteration results from a A to G substitution at nucleotide position 1895, causing the glutamine (Q) at amino acid position 632 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV001974696 | SCV005419606 | uncertain significance | not provided | 2024-05-23 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004731206 | SCV005340293 | likely benign | CENPF-related disorder | 2024-05-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |